CytomX Therapeutics
CTMX
CTMX
117 hedge funds and large institutions have $298M invested in CytomX Therapeutics in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 41 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
-2
Holders Change %
-1.68%
% of All Funds
2.58%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
17
Increased
37
Reduced
41
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AGM
126
Alpine Global Management
New York
| – | -$273K | -32,895 | Closed |
|
|
AG
127
Algert Global
San Francisco,
California
| – | -$269K | -32,403 | Closed |
|
|
HF
128
HRT Financial
New York
| – | -$153K | -18,478 | Closed |
|
129
Capital Fund Management (CFM)
Paris,
France
| – | -$153K | -18,443 | Closed |
|
130
ProShare Advisors
Bethesda,
Maryland
| – | -$132K | -15,930 | Closed |
|
|
HS
131
HighVista Strategies
Boston,
Massachusetts
| – | -$116K | -13,900 | Closed |
|
132
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$47K | -5,630 | Closed |
|
|
TRCT
133
Tower Research Capital (TRC)
New York
| – | -$32K | -3,856 | Closed |
|
134
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$12K | -1,490 | Closed |
|
|
PHK
135
Point72 Hong Kong
Hong Kong
| – | -$9K | -1,135 | Closed |
|